EastGate Biotech Corp. Enters into a Licensing and Distribution Agreement for Glucora, One of Its Nutraceutical Products for the US, Canadian, Central and South American Markets
March 08, 2021 09:30 ET | EastGate Biotech Corp.
The Licensing Fee of $3 Million USD to be Paid in a Combination of Cash and Sales-Driven Funding WEST CALDWELL, NJ and TORONTO, ON, March 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – EastGate...
Optimi Health Logo.jpg
Optimi Health Corp. Closes Oversubscribed Non-Brokered Private Placement for Gross Proceeds of $4.5 Million
September 29, 2020 09:00 ET | Optimi Health Corp.
VANCOUVER, British Columbia, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Optimi Health Corp. (“Optimi” or the “Company”) is pleased to announce that it has closed an oversubscribed non-brokered private...
Logo.jpg
Global Payout Executes Binding MOU to Acquire Controlling Stake in World Innovation Technologies
February 10, 2020 08:00 ET | Global Payout, Inc
SAN DIEGO, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Global Payout Inc. (OTCPink:GOHE) (“Global” or the “Company”) is pleased to announce it has executed a binding Memorandum of Understanding (“MOU”) with...
NeutriSci Files Patent Application
March 01, 2018 08:30 ET | NeutriSci International Inc.
VANCOUVER, British Columbia , March 01, 2018 (GLOBE NEWSWIRE) -- via NetworkWire - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9) the innovator...
NeutriSci Announces a Major R&D MOU With Scientus Pharma to Develop a Medical Cannabinoid Retail Product
January 08, 2018 08:30 ET | NeutriSci International Inc.
VANCOUVER, British Columbia, Jan. 08, 2018 (GLOBE NEWSWIRE) -- NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9), the innovator and pioneer behind...